In 2003, a research study began that is evaluating the safety of an experimental Ebola vaccine in humans. The trial Ebola vaccine (of a type called a DNA vaccine) is similar to other investigational vaccines that hold promise for controlling such diseases as AIDS, influenza, malaria, and hepatitis.
This experimental Ebola vaccine does not contain any infectious material from the Ebola virus. The candidate Ebola vaccine is synthesized using modified, inactivated genes from Ebola virus. This gives the immune system information about viral structures so that it can mount a rapid defense should the real virus ever be encountered.
Previous
Add this article to your Favorites
Email this article
Print